Advertisement
Akebia Therapeutics Resubmits NDA For Vadadustat To FDA
(RTTNews) - Biopharmaceutical company Akebia Therapeutics, Inc. (AKBA) announced Thursday it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for vadadustat for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis.
Vadadustat, Akebia's investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor, is currently approved for use in 35 countries.
Based on standard NDA resubmission review timelines, a letter from the FDA acknowledging that the resubmission is complete, classifying the resubmission, and setting the PDUFA date is expected in 30 days. Akebia expects the FDA to set a PDUFA date of six months from the date of submission.
For More Such Health News, visit rttnews.com
read more
Akebia Therapeutics Expects To Resubmit NDA For Vadadustat NDA In Q3
Biopharmaceutical company Akebia Therapeutics, Inc. (AKBA) announced Thursday that the company expects to resubmit its New Drug Application (NDA) for vadadustat as a treatment for anemia due to chronic kidney disease in adult patients on dialysis by the end of the third quarter of 2023.
RTTNews
|
711 дней спустя
Sensex, Nifty Open Lower After Trump's Fresh Tariff Threat
Indian shares opened on a sluggish note Tuesday after U.S. President Donald Trump threatened to "substantially" raise tariffs on goods imported from India, accusing that the country profited from Russia's war in Ukraine by purchasing large quantities of Russian oil and reselling it on the global market.
RTTNews
|
49 минут назад
Australian Market Extends Early Gains In Mid-market
The Australian stock market is extending its early gains in mid-market trading on Tuesday, adding to the gains in the previous session, following the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is moving above the 8,750 level, with gains across all sectors led by mining, energy and technology stocks.
RTTNews
|
1ч 54мин назад
Asian Markets Track Wall Street Higher
Asian stock markets are trading mostly higher on Tuesday, following the broadly positive cues from Wall Street overnight, amid optimism the weak monthly US jobs data will lead the US Fed to lower interest rates next month. Traders also picked up stocks at a bargain following the recent downturn in the markets. Asian markets closed mixed on Monday.
RTTNews
|
2ч 20мин назад
Sensex, Nifty Set To Open Lower As Trump Again Threatens India With Harsh Tariffs
Indian shares may open on a weak note Tuesday after U.S. President Donald Trump threatened to "substantially" raise tariffs on goods imported from India, accusing that the country profited from Russia's war in Ukraine by purchasing large quantities of Russian oil and reselling it on the global market.
RTTNews
|
2ч 52мин назад
Additional Support Anticipated For Thai Stock Market
The Thai stock market on Monday ended the two-day slide in which it had fallen more than 25 points or 2 percent. The Stock Exchange of Thailand now sits just above the 1,230-point plateau and it's expected to open to the upside again on Tuesday.
RTTNews
|
3ч 24мин назад
Japanese Market Modestly Higher
The Japanese stock market is trading modestly higher on Tuesday, reversing the losses in the previous two sessions, following the broadly positive cues from Wall Street overnight, with the Nikkei 225 moving well above the 40,400 level, with small gains across most sectors led by exporters, automakers and financial stocks.
RTTNews
|
3ч 47мин назад
Rebound Called For Indonesia Stock Market
The Indonesia stock market headed south again on Monday, one session after snapping the two-day slide in which it had dropped almost 140 points or 1.9 percent. The Jakarta Composite Index now sits just shy of the 7,465-point plateau although it's likely to see renewed support on Tuesday.
RTTNews
|
3ч 54мин назад
